US 9255155
Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer
granted A61KA61K49/0032A61K49/0058
Quick answer
US patent 9255155 (Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer) held by The Regents of the University of California expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 52
- CPC classes
- A61K, A61K49/0032, A61K49/0058, A61K51/1075